Why we should use mild stimulation in egg donation
By Guido Pennings,
BioNews
| 11. 30. 2020
There are two strong ethical reasons to avoid harm to egg donors: a duty to minimise harm and the proportionality rule. The general duty to minimise harm applies to all medical interventions but it is even more relevant for donors because they are submitting to the intervention for the benefit of others. Most forms of body material donation will carry with them some harm. This duty does not make that unacceptable but implies that harm is only acceptable when it is unavoidable, and this duty cannot be bypassed by asking the donor for consent. The informed consent form is not a safe conduct for high risks.
Whenever you mention ovarian hyperstimulation syndrome (OHSS) to a clinician, they will reply that it was indeed a serious problem in the past but that it is under control now. The current stimulation protocols bring the risk of OHSS down to zero. However, one wonders how the statistics can be explained as data from the European IVF-Monitoring Consortium show that severe OHSS has not disappeared. Moreover, the American Society for Reproductive Medicine recently calculated that...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...